Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: A contemporary analysis

Diabetes Care

Volumn 38, Issue 5, 2015, Pages 905-912

  Vazquez Benitez, Gabriela ^a   Desai, Jay R ^a   Xu, Stanley ^b   Goodrich, Glenn K ^b   Schroeder, Emily B ^b   Nichols, Gregory A ^c   Sega, Jodi ^d   Butler, Melissa G ^b   Karter, Andrew J ^e   Steiner, John F ^b   Newton, Katherine M ^f   Morales, Leo S ^g   Pathak, Ram D ^h   Thomas, Abraham ⁱ   Reynolds, Kristi ^b   Kirchner, H Lester ^j   Waitzfelder, Beth ^c   Lafata, Jennifer Elston ^i,k   Adibhatla, Renuka ^a   Xu, Zhiyuan ^a   O'Connor, Patrick J ^a   more..

^a HEALTHPARTNERS INSTITUTE   (United States)

^b KAISER PERMANENTE   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e DIVISION OF RESEARCH   (United States)

^f GROUP HEALTH RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h MARSHFIELD CLINIC   (United States)

ⁱ LUTHERAN MEDICAL CENTER   (United States)

^j GEISINGER HEALTH SYSTEM   (United States)

^k VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; RISK REDUCTION; SMOKING; ADVERSE EFFECTS; AGED; BLOOD; BLOOD PRESSURE MEASUREMENT; CAUSE OF DEATH; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HYPERTENSION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CAUSE OF DEATH; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING; STROKE; UNITED STATES; YOUNG ADULT;

EID: 84946731475     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1877     Document Type: Article

References (46)

1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29
2. Diabetes data and statistics [Internet], updated 27 October 2014. Atlanta, GA, Centers for Disease Control and Prevention. Available from http://www.cdc.gov/diabetes/data/. Accessed 5 February 2015
3. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 2014;370:1514-1523
4. Hansen MB, Jensen ML, Carstensen B. Causes of death among diabetic patients in Denmark. Diabetologia 2012;55:294-302
5. Nichols GA, Desai J, Elston Lafata J, et al, .; SUPREME-DM Study Group. Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis 2012;9:E110
6. Hornbrook MC, Hart G, Ellis JL, et al. Building a virtual cancer research organization. J Natl Cancer Inst Monogr 2005;35:12-25
7. Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes Care 2013;36:914-921
8. Zgibor JC, Orchard TJ, Saul M, et al. Developing and validating a diabetes database in a large health system. Diabetes Res Clin Pract 2007;75:313-319
9. Harris SB, Glazier RH, Tompkins JW, et al. Investigating concordance in diabetes diagnosis between primary care charts (electronic medical records) and health administrative data: a retrospective cohort study. BMC Health Serv Res 2010;10:347
10. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl. 1):S14-S80
11. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-520
12. Xu S, Schroeder EB, Shetterly S, et al. Accuracy of hemoglobin A1c imputation using fasting plasma glucose in diabetes research using electronic health records data. Stat Optim Inf Comput 2014;2:93-104
13. Rückinger S, von Kries R, Toschke AM. An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors. BMC Med Res Methodol 2009;9:7
14. Gefeller O, Land M, Eide GE. Averaging attributable fractions in the multifactorial situation: assumptions and interpretation. J Clin Epidemiol 1998;51:437-441
15. Lin H, Allore HG, McAvay G, et al. A method for partitioning the attributable fraction of multiple time-dependent coexisting risk factors for an adverse health outcome. Am J Public Health 2013;103:177-182
16. Jewell N. In Statistics for Epidemiology. London, Chapman & Hall/CRC Press, 2004, p. 84-85
17. Vogel C, Gefeller O. Implications of nondifferential misclassification on estimates of attributable risk. Methods Inf Med 2002;41:342-348
18. Lakshminarayan K, Anderson DC, Jacobs DR Jr, Barber CA, Luepker RV. Stroke rates: 1980-2000: the Minnesota Stroke Survey. Am J Epidemiol 2009;169:1070-1078
19. Rosamond WD, Chambless LE, Sorlie PD, et al. Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000. Am J Epidemiol 2004;160:1137-1146
20. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004;148:99-104
21. Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 2013;36:2271-2279
22. Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Diabetes Care 2008;31:1686-1696
23. Orchard TJ, Temprosa M, Barrett-Connor E, et al, ; Diabetes Prevention Program Outcomes Study Research Group. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med 2013;30:46-55
24. Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2014;2:474-480
25. Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care 2014;37:943-949
26. Straka RJ, Liu LZ, Girase PS, DeLorenzo A, Chapman RH. Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. Cardiovasc Diabetol 2009;8:53
27. Zoungas S, Chalmers J, Neal B, et al, .; ADVANCE-ON Collaborative Group. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 2014;371:1392-1406
28. Skyler JS, Bergenstal R, Bonow RO, et al, .; American Diabetes Association, ; American College of Cardiology Foundation, ; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009;32:187-192
29. Sattar N. Revisiting the links between glycaemia, diabetes and cardiovascular disease. Diabetologia 2013;56:686-695
30. Nichols GA, Joshua-Gotlib S, Parasuraman S. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study. J Gen Intern Med 2013;28:691-697
31. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA 2012;308:581-590
32. Doehner W, Erdmann E, Cairns R, et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol 2012;162:20-26
33. Tseng CH. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis 2013;226:186-192
34. Logue J, Walker JJ, Leese G, et al, .; Scottish Diabetes Research Network Epidemiology Group. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 2013;36:887-893
35. Subedi BH, Joshi PH, Jones SR, Martin SS, Blaha MJ, Michos ED. Current guidelines for high-density lipoprotein cholesterol in therapy and future directions. Vasc Health Risk Manag 2014;10:205-216
36. Tariq SM, Sidhu MS, Toth PP, Boden WE. HDL hypothesis: where do we stand now? Curr Atheroscler Rep 2014;16:398
37. Boden WE, Sidhu MS, Toth PP. The therapeutic role of niacin in dyslipidemia management. J Cardiovasc Pharmacol Ther 2014;19:141-158
38. Lloyd-Jones DM. Niacin and HDL cholesterol - time to face facts. N Engl J Med 2014;371:271-273
39. Joseph JJ, Golden SH. Type 2 diabetes and cardiovascular disease: what next? Curr Opin Endocrinol Diabetes Obes 2014;21:109-120
40. Tanaka Y, Fukui M, Tanaka M, et al. The inter-arm difference in systolic blood pressure is a novel risk marker for subclinical atherosclerosis in patients with type 2 diabetes. Hypertens Res 2014;37:548-552
41. Avery CL, Loehr LR, Baggett C, et al. The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2012;60:1640-1646
42. Loehr LR, Rosamond WD, Poole C, et al. The potentially modifiable burden of incident heart failure due to obesity: the Atherosclerosis Risk in Communities study. Am J Epidemiol 2010;172:781-789
43. Folsom AR, Yamagishi K, Hozawa A, Chambless LE; Atherosclerosis Risk in Communities Study Investigators. Absolute and attributable risks of heart failure incidence in relation to optimal risk factors. Circ Heart Fail 2009;2:11-17
44. Rodgers A, Lawes C, MacMahon S. Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens Suppl 2000;18:S3-S6
45. Wang WS, Wahlqvist ML, Hsu CC, Chang HY, Chang WC, Chen CC. Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan. BMC Public Health 2012;12:111
46. O'Connor PJ, Rush WA, Pronk NP, Cherney LM. Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am J Manag Care 1998;4:335-342